Sulforaphane vs Glucoraphanin: Conversion, Myrosinase & Labels
Sulforaphane vs glucoraphanin explained: precursor vs active compound, myrosinase conversion, bioavailability, direct vs precursor delivery and how to read supplement labels.
Evidence library 15 analyses
Evidence on sulforaphane, NRF2 signalling and human health outcomes, including dosing, bioavailability and formulation.
Complete library
Browse every published guide, review and evidence update in this topic.
Sulforaphane vs glucoraphanin explained: precursor vs active compound, myrosinase conversion, bioavailability, direct vs precursor delivery and how to read supplement labels.
Foods high in sulforaphane explained by human evidence: broccoli sprouts, raw vs cooked broccoli, mustard-seed myrosinase, cruciferous vegetables and preparation.
Sulforaphane side effects and safety explained by formulation and exposure: GI symptoms, thyroid data, high-dose stabilized sulforaphane, drug-interaction uncertainty and special populations.
Sulforaphane dosage explained without label confusion: human trial doses, µmol-to-mg conversion, glucoraphanin vs sulforaphane, myrosinase, bioavailability and safety.
Sulforaphane benefits ranked by human evidence across 37 papers: bioavailability, pollutant biomarkers, blood sugar, autism, NRF2, H. pylori, cancer and key limitations.
The evidence-led sulforaphane supplement pillar: forms, active myrosinase, delivered dose, bioavailability, benefits, dosage, safety, foods and the complete 37-paper evidence architecture.